{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:43:39Z","timestamp":1782809019274,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.04.042","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T11:00:40Z","timestamp":1398769240000},"page":"3357-3361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Konrad","family":"Bochennek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Allwinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver T.","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klingebiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.04.042_bib0005","first-page":"A842","article-title":"Krebserkrankungen bei Kindern","volume":"100","author":"Creutzig","year":"2003","journal-title":"Deutsches \u00c4rzteblatt"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00043426-199709000-00001","article-title":"Therapy-induced alterations in host defense in children receiving chemotherapy","volume":"19","author":"Lehrnbecher","year":"1997","journal-title":"J Ped Hematol Oncol"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1470-2045(08)70071-8","article-title":"Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies","volume":"9","author":"Lehrnbecher","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pbc.22256","article-title":"Survivors of childhood cancer: an Australian audit of vaccination status after treatment","volume":"54","author":"Crawford","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0025","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0264-410X(99)00510-1","article-title":"Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial","volume":"18","author":"Trannoy","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0030","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/S0264-410X(03)00341-4","article-title":"Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life","volume":"21","author":"Gans","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1289\/ehp.01109757","article-title":"Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors","volume":"109","author":"Van Loveren","year":"2001","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1067\/mpd.2001.116051","article-title":"Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy","volume":"139","author":"Vessey","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","article-title":"Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0050","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00103-013-1790-6","article-title":"Durchimpfung und Pr\u00e4valenz von IgG-Antik\u00f6rpern gegen Masern bei Kindern und Jugendlichen in Deutschland","volume":"56","author":"Poethko-M\u00fcller","year":"2013","journal-title":"Bundesgesundheitbl"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0055","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.vaccine.2013.12.065","article-title":"Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella","volume":"32","author":"Streng","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0060","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1086\/651950","article-title":"Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer","volume":"201","author":"Wiser","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1651-2227.1995.tb13605.x","article-title":"Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow-up","volume":"84","author":"Abrahamsson","year":"1995","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2141.2000.02143.x","article-title":"Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease","volume":"110","author":"van Wering","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF01964245","article-title":"Fluctuation of virus antibody levels in healthy adults","volume":"7","author":"Meurman","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0080","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.2010.08522.x","article-title":"Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules","volume":"152","author":"Lehrnbecher","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0085","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2141.2009.07903.x","article-title":"Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia","volume":"147","author":"Lehrnbecher","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0090","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1542\/peds.109.6.e91","article-title":"Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens","volume":"109","author":"Nilsson","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cncr.20384","article-title":"Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy","volume":"101","author":"Zignol","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0100","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jpeds.2004.12.043","article-title":"Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens","volume":"146","author":"Brodtman","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0105","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.vaccine.2010.12.084","article-title":"Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: a report from the Late Effects Surveillance System","volume":"29","author":"Paulides","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/pbc.21327","article-title":"Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL","volume":"50","author":"Kosmidis","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00043426-199809000-00008","article-title":"Immune recovery in children with malignancy after cessation of chemotherapy","volume":"20","author":"Mustafa","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0120","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI108532","article-title":"Long term effects of radiation on T and B lymphocytes in the peripheral blood of patients with Hodgkin's disease","volume":"58","author":"Fuks","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0125","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/sj.leu.2404326","article-title":"Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review","volume":"20","author":"van Tilburg","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/pbc.20255","article-title":"Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group","volume":"44","author":"Ek","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.vaccine.2014.04.042_bib0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2007-990290","article-title":"Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05\/92","volume":"219","author":"Calaminus","year":"2007","journal-title":"Klin Padiatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:57:52Z","timestamp":1538650672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14005805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":27,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14005805"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}